Showing results (11-20 of 34) with videos related to
Sort By:
Pageof 4
Frontiers in Immunology|September 12, 2019
Systemic Inflammation and the Increased Risk of Inflamm-Aging and Age-Associated Diseases in People Living With HIV on Long Term Suppressive Antiretroviral TherapyHemalatha Babu, Anoop T Ambikan, Erin E Gabriel, et al.Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|December 9, 2022
Estimating severe acute respiratory coronavirus virus 2 (SARS-CoV-2) seroprevalence from residual clinical blood samples, January-March 2021Daniel S Graciaa, Hans P Verkerke, Jeannette Guarner, et al.Cell Reports|March 2, 2022
Structure-guided changes at the V2 apex of HIV-1 clade C trimer enhance elicitation of autologous neutralizing and broad V1V2-scaffold antibodiesAnusmita Sahoo, Edgar A Hodge, Celia C LaBranche, et al.International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|January 4, 2023
Antibody response, neutralizing potency, and transplacental antibody transfer following SARS-CoV-2 infection versus mRNA-1273, BNT162b2 COVID-19 vaccination in pregnancyCarolynn M Dude, Naima T Joseph, Alexandra D Forrest, et al.Open Forum Infectious Diseases|May 22, 2023
Investigation of Blood Plasma Viral Nucleocapsid Antigen as a Marker of Active Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant InfectionGregory L Damhorst, Nils Schoof, Phuong-Vi Nguyen, et al.Cell Reports|September 14, 2023
Light chain of a public SARS-CoV-2 class-3 antibody modulates neutralization against OmicronAnamika Patel, Sanjeev Kumar, Lilin Lai, et al.Scientific Reports|July 30, 2024
Emergence of SARS-CoV-2 omicron variant JN.1 in Tamil Nadu, India - Clinical characteristics and novel mutationsSivaprakasam T Selvavinayagam, Sathish Sankar, Yean K Yong, et al.Medrxiv : the Preprint Server for Health Sciences|May 3, 2024
Emergence of SARS-CoV-2 Omicron Variant JN.1 in Tamil Nadu, India - Clinical Characteristics and Novel MutationsSivaprakasam T Selvavinayagam, Sathish Sankar, Yean K Yong, et al.Blood|June 27, 2023
Blood group A enhances SARS-CoV-2 infectionShang-Chuen Wu, Connie M Arthur, Hau-Ming Jan, et al.Medrxiv : the Preprint Server for Health Sciences|July 3, 2023
Poor immunogenicity upon SARS-CoV-2 mRNA vaccinations in autoimmune SLE patients is associated with pronounced EF-mediated responses and anti-BAFF/Belimumab treatmentCaterina E Faliti, Fabliha A Anam, Narayanaiah Cheedarla, et al.Pageof 4